Publicacions en què col·labora amb FRANCISCO ALÉN FARIÑAS (7)

2022

  1. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

    Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461

2021

  1. Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108

2019

  1. Oleoylethanolamide, neuroinflammation, and alcohol abuse

    Frontiers in Molecular Neuroscience, Vol. 11

2017

  1. A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity

    Journal of Medicinal Chemistry, Vol. 60, Núm. 23, pp. 9575-9584

  2. Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration

    Addiction Biology, Vol. 22, Núm. 3, pp. 724-741

2016

  1. Erratum: Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats (International Journal of Neuropsychopharmacology 18:6 (DOI: 10.1093/ijnp/pyu111)

    International Journal of Neuropsychopharmacology

2015

  1. Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats

    International Journal of Neuropsychopharmacology, Vol. 18, Núm. 6, pp. 1-14